EGFR and cancer: The anti‐EGFR antibody conjugated on colloidal GNP specifically and homogeneously binds to the surface of the cancer cells with 600% greater affinity than with the non‐cancerous cells as evident by Surface Plasmon Resonance Imaging and Spectroscopy in two malignant oral epithelial cell lines [27].